Ignite Creation Date:
2025-12-24 @ 12:16 PM
Ignite Modification Date:
2025-12-27 @ 9:54 PM
Study NCT ID:
NCT05162261
Status:
COMPLETED
Last Update Posted:
2025-01-22
First Post:
2021-11-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
Sponsor:
Novoxel Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-21
First Submit QC Date:
None
Study First Post Date:
2021-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-03
Results First Submit QC Date:
None
Results First Post Date:
2025-01-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-29
Last Update Post Date:
2025-01-22
Last Update Post Date Type:
ACTUAL